Skip to content

Treatment Options for Uterine Cancer: An Overview

Uterine cancer treatments: A look at variations and additional information

Uterine cancer treatments: Varieties and supplemental information
Uterine cancer treatments: Varieties and supplemental information

Treatment Options for Uterine Cancer: An Overview

Uterine cancer, a type of gynecologic cancer, can be a challenging diagnosis, but understanding the available treatment options can provide some clarity. There are four common treatment methods for uterine cancer: surgery, radiation therapy, chemotherapy, and hormone therapy.

Surgery is often the first-line treatment, typically involving a hysterectomy (removal of the uterus) and possible removal of surrounding lymph nodes. The main benefit is to physically remove the tumor, which can be curative in early-stage disease. Side effects may include bleeding, infection, damage to surrounding organs, and impacts on fertility and hormonal status if ovaries are removed.

Radiation therapy uses high-energy rays to destroy cancer cells and is often used after surgery or for patients who cannot undergo surgery. It helps reduce recurrence risk and control local tumor growth. Side effects can include fatigue, skin irritation, vaginal dryness or stenosis, and bowel or bladder irritation depending on the radiation field.

Chemotherapy is systemic therapy designed to kill cancer cells throughout the body and is standard for advanced or metastatic endometrial cancer. The most commonly recommended regimen is carboplatin combined with paclitaxel, which shows about a 50% objective response rate and a median overall survival of 15 to 29 months. Other agents include doxorubicin, cisplatin, and docetaxel. Benefits include control of metastatic disease and prolonged survival, but side effects commonly include nausea, vomiting, hair loss, low blood counts (leading to infection risk), neuropathy, and fatigue.

Hormone therapy is used mainly for cancers expressing estrogen or progesterone receptors. It works by blocking or reducing hormone levels to slow cancer growth. Common hormone drugs are progestins (e.g., medroxyprogesterone acetate), selective estrogen receptor modulators (SERMs) like tamoxifen, aromatase inhibitors (letrozole), and selective estrogen receptor degraders (SERDs). Benefits include a targeted approach with often fewer severe side effects compared to chemotherapy, but side effects may include hot flashes, mood changes, vaginal dryness, and thromboembolic risk.

In summary, these treatments can be used alone or in combination depending on stage, tumor type, and patient factors. Targeted therapies and immunotherapies are emerging but are less standard as of now. It is crucial for a person to discuss their treatment options with a medical professional to determine the best treatment plan for them and their specific diagnosis. Early detection of uterine cancer often leads to a better outlook. Alternative treatments such as herbal supplements, acupuncture, and dietary changes are not standard treatments for uterine cancer, but should be discussed with a healthcare professional before starting any alternative treatment.

Read also:

Latest

Supporters Rally for Hospice Bottrop Patients

Supporters Rally for Hospice Bottrop Patients

Year-over-year increase in donations: Initial sum of 9,000 euros grew to nearly 33,000 euros this year. In total, dentists Dr. Jürgen von der Gathen, Dr. Johannes von der Gathen, Dr. Dieter Jansen, Ulrich Reich, and Dr. Maik Janßen have contributed over 164,000 euros to the association, as...